cis-2-(9-Fluorenylmethoxycarbonylamino)cyclohex-4-enecarboxylic acid
|
- $45 - $429
- Product name: cis-2-(9-Fluorenylmethoxycarbonylamino)cyclohex-4-enecarboxylic acid
- CAS: 1212305-88-8
- MF: C22H21NO4
- MW: 363.41
- EINECS:
- MDL Number:MFCD09750523
- Synonyms:cis-2-(9-Fluorenylmethoxycarbonylamino)cyclohex-4-enecarboxylic acid;(1R,6S)-6-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)cyclohex-3-ene-1-carboxylic acid;3-Cyclohexene-1-carboxylic acid, 6-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-, (1R,6S)-rel-;6-(Fmoc-NH)-cis-cyclohex-3-ene-COOH;(1R,6S)-6-{[(9H-Fluoren-9-ylmethoxy)carbonyl]amino}-3-cyclohexene-1-carboxylicacid
3 prices
Selected condition：
Brand
- AK Scientific
- Crysdot
- TRC
Package
- 50mg
- 1g
- 10g
- ManufacturerAK Scientific
- Product number1092AD
- Product descriptionFmoc-(1R,2S)-(-)-2-aminocyclohex-4-ene-carboxylicacid
- Packaging1g
- Price$313
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD21017650
- Product descriptionFmoc-(1R,2S)-(-)-2-aminocyclohex-4-ene-carboxylicacid 95+%
- Packaging10g
- Price$429
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberF647585
- Product descriptioncis-1-(9-Fluorenylmethyloxycarbonyl-amino)-cyclohex-4-enyl-2-carboxylicAcid
- Packaging50mg
- Price$45
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| AK Scientific | 1092AD | Fmoc-(1R,2S)-(-)-2-aminocyclohex-4-ene-carboxylicacid | 1g | $313 | 2021-12-16 | Buy |
| Crysdot | CD21017650 | Fmoc-(1R,2S)-(-)-2-aminocyclohex-4-ene-carboxylicacid 95+% | 10g | $429 | 2021-12-16 | Buy |
| TRC | F647585 | cis-1-(9-Fluorenylmethyloxycarbonyl-amino)-cyclohex-4-enyl-2-carboxylicAcid | 50mg | $45 | 2021-12-16 | Buy |
Properties
Boiling point :600.6±55.0 °C(Predicted)
Density :1.32±0.1 g/cm3(Predicted)
pka :4.38±0.40(Predicted)
Density :1.32±0.1 g/cm3(Predicted)
pka :4.38±0.40(Predicted)
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|